Development of isolated hepatic perfusion for patients who have unresectable hepatic malignancies

Surgical Oncology Clinics of North America
Adriana Jones, H R Alexander

Abstract

Isolated hepatic perfusion (IHP) has a role in the treatment of colorectal carcinoma, ocular melanoma, and neuroendocrine tumor liver metastases. Outcomes data with IHP have improved with better patient selection, adoption of standard operative techniques, use of appropriate types and doses of chemotherapeutics, and careful measures of efficacy and survival. The percutaneous approach to IHP, the treatment of additional tumor types (eg, unresectable hepatocellular carcinoma, gastrointestinal sarcoma, occult primaries), the use of other agents within the IHP circuit, and gene therapy all deserve additional attention.

References

Mar 1, 1991·Ophthalmology·E S GragoudasM D Spar
Aug 1, 1987·World Journal of Surgery·K SchwemmleB Rieck
Nov 1, 1986·Archives of Surgery·J L Skibba, E J Quebbeman
Jul 15, 1983·Cancer·S RajpalC P Karakousis
Nov 1, 1984·Journal of Surgical Oncology·E J QuebbemanR J Petroff
Apr 1, 1994·Surgical Oncology·L R HafströmT S Scherstén
Nov 1, 1995·World Journal of Surgery·J P ArnestadG Schlag
Oct 1, 1996·Japanese Journal of Clinical Oncology·A MarinelliC J van de Velde
Nov 1, 1996·Seminars in Surgical Oncology·H R AlexanderD L Bartlett
Apr 11, 2000·Journal of the American College of Surgeons·R S ChamberlainL H Blumgart
Mar 27, 2001·Transplantation Proceedings·J CoppaV Mazzaferro
May 15, 2002·The Cancer Journal·Nancy M Carroll, H Richard Alexander
Jun 12, 2002·Annals of Oncology : Official Journal of the European Society for Medical Oncology·E BajettaE Bombardieri
Dec 31, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Fairooz KabbinavarEmily Bergsland
Jun 4, 2004·The New England Journal of Medicine·Herbert HurwitzFairooz Kabbinavar
Jul 23, 2004·The New England Journal of Medicine·David CunninghamEric Van Cutsem
Aug 4, 2004·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·J RothbarthC J H van de Velde
Nov 25, 2004·The Oncologist·Amelia Grover, H Richard Alexander
Mar 2, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Fairooz F KabbinavarWilliam F Novotny
Mar 19, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Gregory D LeonardNancy E Kemeny
May 4, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Fairooz F KabbinavarSomnath Sarkar
Nov 1, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Petra RietschelPaul B Chapman
Mar 1, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Nancy E KemenyRobert J Mayer
Mar 4, 2006·CA: a Cancer Journal for Clinicians·Ahmedin JemalMichael J Thun
Jul 26, 2006·Digestive Diseases and Sciences·Matthew H KulkeCharles S Fuchs
Aug 19, 2006·Anti-cancer Drugs·Larry K Kvols, Eugene A Woltering

❮ Previous
Next ❯

Citations

Feb 9, 2012·Langmuir : the ACS Journal of Surfaces and Colloids·Jianjun MiaoRobert J Linhardt
Oct 20, 2009·The Surgical Clinics of North America·Aarti MathurSteven K Libutti
Oct 30, 2013·Journal of Surgical Oncology·Maki Yamamoto, Jonathan S Zager

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.